Neuroactive steroids and peripheral neuropathy

Ilaria Roglio, Silvia Giatti, Marzia Pesaresi, Roberto Bianchi, Guido Cavaletti, Giuseppe Lauria, Luis Miguel Garcia-Segura, Roberto Cosimo Melcangi

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Peripheral neuropathy, either inherited or acquired, represents a very common disorder for which effective clinical treatments are not available yet. Observations here summarized indicate that neuroactive steroids, such as progesterone, testosterone and their reduced metabolites, might represent a promising therapeutic option. Peripheral nerves are able to synthesize and metabolize neuroactive steroids and are a target for these molecules, since they express classical and non-classical steroid receptors. Neuroactive steroids modulate the expression of key transcription factors for Schwann cell function, regulate Schwann cell proliferation and promote the expression of myelin proteins involved in the maintenance of myelin multilamellar structure, such as myelin protein zero and peripheral myelin protein 22. These actions may result in the protection and regeneration of peripheral nerves affected by different forms of pathological alterations. Indeed, neuroactive steroids are able to counteract biochemical, morphological and functional alterations of peripheral nerves in different experimental models of neuropathy, including the alterations caused by aging, diabetic neuropathy and physical injury. Therefore, neuroactive steroids, pharmacological agents able to increase their local synthesis and synthetic ligands for their receptors have a promising potential for the treatment of different forms of peripheral neuropathy.

Original languageEnglish
Pages (from-to)460-469
Number of pages10
JournalBrain Research Reviews
Volume57
Issue number2
DOIs
Publication statusPublished - Mar 14 2008

Fingerprint

Peripheral Nervous System Diseases
Steroids
Peripheral Nerves
Myelin Proteins
Schwann Cells
Myelin P0 Protein
Diabetic Neuropathies
Steroid Receptors
Myelin Sheath
Progesterone
Testosterone
Regeneration
Transcription Factors
Theoretical Models
Maintenance
Cell Proliferation
Pharmacology
Ligands
Wounds and Injuries

Keywords

  • 5α-reductase
  • Progesterone
  • Schwann cells
  • Sciatic nerve
  • Testosterone
  • Tetrahydroprogesterone

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Roglio, I., Giatti, S., Pesaresi, M., Bianchi, R., Cavaletti, G., Lauria, G., ... Melcangi, R. C. (2008). Neuroactive steroids and peripheral neuropathy. Brain Research Reviews, 57(2), 460-469. https://doi.org/10.1016/j.brainresrev.2007.04.010

Neuroactive steroids and peripheral neuropathy. / Roglio, Ilaria; Giatti, Silvia; Pesaresi, Marzia; Bianchi, Roberto; Cavaletti, Guido; Lauria, Giuseppe; Garcia-Segura, Luis Miguel; Melcangi, Roberto Cosimo.

In: Brain Research Reviews, Vol. 57, No. 2, 14.03.2008, p. 460-469.

Research output: Contribution to journalArticle

Roglio, I, Giatti, S, Pesaresi, M, Bianchi, R, Cavaletti, G, Lauria, G, Garcia-Segura, LM & Melcangi, RC 2008, 'Neuroactive steroids and peripheral neuropathy', Brain Research Reviews, vol. 57, no. 2, pp. 460-469. https://doi.org/10.1016/j.brainresrev.2007.04.010
Roglio I, Giatti S, Pesaresi M, Bianchi R, Cavaletti G, Lauria G et al. Neuroactive steroids and peripheral neuropathy. Brain Research Reviews. 2008 Mar 14;57(2):460-469. https://doi.org/10.1016/j.brainresrev.2007.04.010
Roglio, Ilaria ; Giatti, Silvia ; Pesaresi, Marzia ; Bianchi, Roberto ; Cavaletti, Guido ; Lauria, Giuseppe ; Garcia-Segura, Luis Miguel ; Melcangi, Roberto Cosimo. / Neuroactive steroids and peripheral neuropathy. In: Brain Research Reviews. 2008 ; Vol. 57, No. 2. pp. 460-469.
@article{22fff4c5f4e3480a818c7a95e859190a,
title = "Neuroactive steroids and peripheral neuropathy",
abstract = "Peripheral neuropathy, either inherited or acquired, represents a very common disorder for which effective clinical treatments are not available yet. Observations here summarized indicate that neuroactive steroids, such as progesterone, testosterone and their reduced metabolites, might represent a promising therapeutic option. Peripheral nerves are able to synthesize and metabolize neuroactive steroids and are a target for these molecules, since they express classical and non-classical steroid receptors. Neuroactive steroids modulate the expression of key transcription factors for Schwann cell function, regulate Schwann cell proliferation and promote the expression of myelin proteins involved in the maintenance of myelin multilamellar structure, such as myelin protein zero and peripheral myelin protein 22. These actions may result in the protection and regeneration of peripheral nerves affected by different forms of pathological alterations. Indeed, neuroactive steroids are able to counteract biochemical, morphological and functional alterations of peripheral nerves in different experimental models of neuropathy, including the alterations caused by aging, diabetic neuropathy and physical injury. Therefore, neuroactive steroids, pharmacological agents able to increase their local synthesis and synthetic ligands for their receptors have a promising potential for the treatment of different forms of peripheral neuropathy.",
keywords = "5α-reductase, Progesterone, Schwann cells, Sciatic nerve, Testosterone, Tetrahydroprogesterone",
author = "Ilaria Roglio and Silvia Giatti and Marzia Pesaresi and Roberto Bianchi and Guido Cavaletti and Giuseppe Lauria and Garcia-Segura, {Luis Miguel} and Melcangi, {Roberto Cosimo}",
year = "2008",
month = "3",
day = "14",
doi = "10.1016/j.brainresrev.2007.04.010",
language = "English",
volume = "57",
pages = "460--469",
journal = "Brain Research Reviews",
issn = "0165-0173",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Neuroactive steroids and peripheral neuropathy

AU - Roglio, Ilaria

AU - Giatti, Silvia

AU - Pesaresi, Marzia

AU - Bianchi, Roberto

AU - Cavaletti, Guido

AU - Lauria, Giuseppe

AU - Garcia-Segura, Luis Miguel

AU - Melcangi, Roberto Cosimo

PY - 2008/3/14

Y1 - 2008/3/14

N2 - Peripheral neuropathy, either inherited or acquired, represents a very common disorder for which effective clinical treatments are not available yet. Observations here summarized indicate that neuroactive steroids, such as progesterone, testosterone and their reduced metabolites, might represent a promising therapeutic option. Peripheral nerves are able to synthesize and metabolize neuroactive steroids and are a target for these molecules, since they express classical and non-classical steroid receptors. Neuroactive steroids modulate the expression of key transcription factors for Schwann cell function, regulate Schwann cell proliferation and promote the expression of myelin proteins involved in the maintenance of myelin multilamellar structure, such as myelin protein zero and peripheral myelin protein 22. These actions may result in the protection and regeneration of peripheral nerves affected by different forms of pathological alterations. Indeed, neuroactive steroids are able to counteract biochemical, morphological and functional alterations of peripheral nerves in different experimental models of neuropathy, including the alterations caused by aging, diabetic neuropathy and physical injury. Therefore, neuroactive steroids, pharmacological agents able to increase their local synthesis and synthetic ligands for their receptors have a promising potential for the treatment of different forms of peripheral neuropathy.

AB - Peripheral neuropathy, either inherited or acquired, represents a very common disorder for which effective clinical treatments are not available yet. Observations here summarized indicate that neuroactive steroids, such as progesterone, testosterone and their reduced metabolites, might represent a promising therapeutic option. Peripheral nerves are able to synthesize and metabolize neuroactive steroids and are a target for these molecules, since they express classical and non-classical steroid receptors. Neuroactive steroids modulate the expression of key transcription factors for Schwann cell function, regulate Schwann cell proliferation and promote the expression of myelin proteins involved in the maintenance of myelin multilamellar structure, such as myelin protein zero and peripheral myelin protein 22. These actions may result in the protection and regeneration of peripheral nerves affected by different forms of pathological alterations. Indeed, neuroactive steroids are able to counteract biochemical, morphological and functional alterations of peripheral nerves in different experimental models of neuropathy, including the alterations caused by aging, diabetic neuropathy and physical injury. Therefore, neuroactive steroids, pharmacological agents able to increase their local synthesis and synthetic ligands for their receptors have a promising potential for the treatment of different forms of peripheral neuropathy.

KW - 5α-reductase

KW - Progesterone

KW - Schwann cells

KW - Sciatic nerve

KW - Testosterone

KW - Tetrahydroprogesterone

UR - http://www.scopus.com/inward/record.url?scp=40749124836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40749124836&partnerID=8YFLogxK

U2 - 10.1016/j.brainresrev.2007.04.010

DO - 10.1016/j.brainresrev.2007.04.010

M3 - Article

C2 - 17543391

AN - SCOPUS:40749124836

VL - 57

SP - 460

EP - 469

JO - Brain Research Reviews

JF - Brain Research Reviews

SN - 0165-0173

IS - 2

ER -